University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Anticholinergic medication exposure predicts poor physical capability : Findings from a large prospective cohort study in England.

Simple item page
dc.contributor.authorYrjana, Kaisa R.
dc.contributor.authorKeevil, Victoria L.
dc.contributor.authorSoiza, Roy L
dc.contributor.authorLuben, Robert N.
dc.contributor.authorWareham, Nicholas J.
dc.contributor.authorKhaw, Kay-Tee
dc.contributor.authorMyint, Phyo K.
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2020-07-31T08:25:01Z
dc.date.available2020-07-31T08:25:01Z
dc.date.issued2020-12-01
dc.descriptionFunding: The EPIC-Norfolk study has been supported by grants from Medical Research Council [grant numbers G9502233, G0401527] and Cancer Research UK [grant number C864/A8257]; and the third health examination clinic was supported by a grant from Research into Ageing [grant number 262]. The funders have had no roles in the study design or interpretation of the results. VLK is supported by a MRC/NIHR Clinical Academic Research Partnership Grant. KRY is currently employed as a regulatory affairs student assistant at Lundbeck (Ottiliavej 9, 2500 Copenhagen, Denmark) Acknowledgements: We would like to thank the participants of the EPIC-Norfolk study as well as the participating general practitioners and administrative and research staff who made the study possible.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent273556
dc.identifier172196907
dc.identifierccb3e5da-12c1-4ee0-9979-92e72347af45
dc.identifier85088784192
dc.identifier33158488
dc.identifier.citationYrjana, K R, Keevil, V L, Soiza, R L, Luben, R N, Wareham, N J, Khaw, K-T & Myint, P K 2020, 'Anticholinergic medication exposure predicts poor physical capability : Findings from a large prospective cohort study in England.', Maturitas, vol. 142, pp. 55-63. https://doi.org/10.1016/j.maturitas.2020.07.006en
dc.identifier.doi10.1016/j.maturitas.2020.07.006
dc.identifier.issn0378-5122
dc.identifier.otherORCID: /0000-0003-3852-6158/work/163198685
dc.identifier.urihttps://hdl.handle.net/2164/14822
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85088784192&partnerID=8YFLogxKen
dc.identifier.vol142en
dc.language.isoeng
dc.relation.ispartofMaturitasen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectPhysical capabilityen
dc.subjectAnticholinergic burdenen
dc.subjectOlder peopleen
dc.subjectR Medicineen
dc.subjectGeneral Biochemistry,Genetics and Molecular Biologyen
dc.subjectObstetrics and Gynaecologyen
dc.subjectMedical Research Council (MRC)en
dc.subjectG9502233en
dc.subjectG0401527en
dc.subjectCancer Research UKen
dc.subjectC864/A8257en
dc.subjectOtheren
dc.subject262]en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccRen
dc.titleAnticholinergic medication exposure predicts poor physical capability : Findings from a large prospective cohort study in England.en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Yrjana_et_al_Maturitas_AnticholinergicMedicationExposure_VoR.pdf
Size:
267.14 KB
Format:
Adobe Portable Document Format
Download

Collections

All research